Axsome Therapeutics Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (17)

Latest Posts

About This Stock More About This Stock
Healthcare And Biotechs Feel The Heat As The Market At New Highs
Article By: Tarun Chandra, CFA
Wednesday, May 1, 2019 12:14 PM EDT
The stock market has continued to edge higher and the two major indexes, the Nasdaq (QQQ) and S&P 500 (SPY​), touched the all-time high milestone last week.
In this article: ACAD, ALXN, ARRY, AMRN, ARWR, AXSM, ASND
Read
Axsome Looks Good On Multiple Catalysts: Fast Track Designation Eases Liquidity Concerns
Article By: KKD Healthcare Analytics
Tuesday, June 20, 2017 11:27 AM EDT
Axsome Therapeutics Inc. (AXSM) has multiple catalysts coming up in the near future as it has two main drug candidates under Phase 3 testing for multiple conditions. The stock has shown strength as it gained over 12 percent in the past one month.
In this article: AXSM
Read
Should You Invest In Axsome Therapeutics?
Article By: Jason Napodano
Monday, May 8, 2017 10:48 AM EDT
Axsome has good insider ownership, plenty of cash, drugs with proven mechanisms of action, strong IP, and plenty of catalysts. Should it be in your portfolio?
In this article: AXSM
Read
Premarket Biotech Digest 2016-03-29: ACAD Nuplazid Review, APRI Tumbles, PBYI Delays NDA Filing
Article By: KKD Healthcare Analytics
Tuesday, March 29, 2016 8:31 AM EDT
Daily premarket biotech digest
In this article: ACAD, ALDR, EGRX, AXSM, BPMX, PBYI, AERI, APRI, AGLE
Read

PARTNER HEADLINES

Latest Tweets for $AXSM

No tweets yet!